We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Abbott Diagnostics

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Biosensing Platform Diagnoses Diseases Through Single Molecule Detection

By LabMedica International staff writers
Posted on 15 Sep 2020
Print article
Image: Illustration depicting the marriage of DNA nanotechnology and bioelectronics (Photo courtesy of EatFishDesign)
Image: Illustration depicting the marriage of DNA nanotechnology and bioelectronics (Photo courtesy of EatFishDesign)
A new diagnostic approach employs a DNA origami biosensor platform coupled with a nanopore read-out that enables individual biomarker detection.

The ability to detect low concentrations of biomarkers in patient samples is one of the cornerstones of modern healthcare. In general, biosensing approaches are based on measuring signals resulting from the interaction of a large ensemble of molecules with the sensor. To increase the sensitivity of this approach, investigators at the University of Leeds (United Kingdom) developed a biosensor platform using DNA origami, which featured a central cavity with a target-specific DNA aptamer coupled with a nanopore read-out to enable individual biomarker detection.

DNA origami is the nanoscale folding of DNA to create non-arbitrary two- and three-dimensional nanoscale shapes. The current method of DNA origami involves the folding of a long single strand of viral DNA aided by multiple smaller "staple" strands. These shorter strands bind the longer in various places, resulting in the formation of a pre-defined two- or three-dimensional shape.

Aptamers are nucleic acid species that have been engineered through repeated rounds of in vitro selection to bind to various molecular targets such as small molecules, proteins, nucleic acids, and even cells, tissues, and organisms. Aptamers are useful in biotechnological and therapeutic applications as they offer molecular recognition properties that rival that of antibodies. In addition to their discriminate recognition, aptamers offer advantages over antibodies as they can be engineered completely in a test tube, are readily produced by chemical synthesis, possess desirable storage properties, and elicit little or no immunogenicity in therapeutic applications.

The University of Leeds investigators demonstrated that DNA aptamer-functionalized DNA origami could capture an analyte of interest, and that the occupied and unoccupied DNA origami’s translocation fingerprints were readily distinguishable. In this study, they revealed a biosensing platform with a three nanomolar limit of detection, which was capable of detecting human C-reactive protein (CRP) in clinically relevant fluids.

The investigators reported that in addition to the characteristically different peak shape, also the peak amplitude, and dwell time could be used to distinguish occupied from unoccupied carriers. The read-out was entirely electrical so it could be miniaturized, enabling point-of-care detection. Taken together, this enabled quantitative biosensing via counting of individual occupied DNA origami carriers, which was demonstrated in physiological solutions and diluted human plasma.

First author, Dr. Mukhil Raveendran, a researcher at the University of Leeds, said, "One of the main advantages is the minimal sample needed. We are able to isolate individual molecules from small samples to identify specific illnesses. The process is very quick, and takes just minutes to provide results. The captured biomarkers are then read with nanopores and we can do this one molecule at a time. By coupling DNA origami and nanopores we are able to quantitatively detect disease biomarkers with single molecule sensitivity."

The DNA origami-nanopore biosensing platform was described in the September 1, 2020, online edition of the journal Nature Communications.

Related Links:
University of Leeds


Print article

Channels

Immunology

view channel
Image: An enzyme-linked immunosorbent assay for mannose-binding lectin found that this molecule is associated with coagulopathy in severe COVID-19 patients (Photo courtesy of Getty Images).

Mannose-Binding Lectin Associated with Coagulopathy in Severe COVID-19

The ongoing COVID-19 pandemic has caused significant morbidity and mortality worldwide, as well as profound effects on society. COVID-19 patients have an increased risk of thromboembolic (TE) complications,... Read more

Industry News

view channel
Illustration

2020 AACC Annual Scientific Meeting & Clinical Lab Expo to Be an All Virtual Event Due to Coronavirus Pandemic

The American Association for Clinical Chemistry (AACC Washington, DC, USA) has decided to hold the 2020 AACC Annual Scientific Meeting & Clinical Lab Expo as a virtual event, rather than as a live... Read more
Copyright © 2000-2020 Globetech Media. All rights reserved.